Dapagliflozin Is A New Drug For The Treatment Of Type Two Diabetes.
A young drug, the in the first place in its class, gives added blood sugar switch to people with type 2 diabetes who are already taking the glucose-lowering medication metformin. The unexplored agent, dapagliflozin, which also helped patients lose weight, is novel in that it does not work promptly on the body's insulin mechanisms, according to a study appearing in the June 26 issue of The Lancet and slated for image at the annual meeting of the American Diabetes Association (ADA) in Orlando proextenderdeluxe.com. "It will possibly be used as an add-on therapy," said study lead author Clifford Bailey, a chemical pathologist and professor of clinical art at Aston University in Birmingham, UK "If you don't degree get to target with the first therapy tried, this approach would offer you an opportunity expectedly to maintain improved control".
Bailey, who could not predict if or when the drug might get final approval from drug regulatory authorities, also trenchant out that dapagliflozin is flexible, meaning it can be used with various other treatments and at more or less any stage in the disease. "It's a company add-on," agreed Dr Stanley Mirsky, associate clinical professor of metabolic diseases at Mount Sinai Medical Center in New York City surgery. "is it a ponder drug? no. It may leeway a small role".
The study was funded by Bristol-Myers Squibb and AstraZeneca, which are developing dapagliflozin together. Dapagliflozin guts by stimulating the kidneys to eliminate more glucose from the body via urine. In this analyse of 534 adult patients with type 2 diabetes who were already taking metformin, the highest prescribe of dapagliflozin (10 milligrams daily) was associated with a 0,84 percent dwindling in HbA1c levels.
HbA1c is a measure of blood sugar control over time. Participants taking 5 mg of the downer saw a 0,70 percent decrease in HbA1c levels, while those taking 2.5 mg had a 0,67 percent decrease. In the placebo group, the decrement in HbA1c was 0,3 percent, the bone up found.
